• Explore /
  • Poster
  • / The phase I study of concurrent chemoradiotherapy using a combination of gemcitabine and nab-paclitaxel for unresectable locally advanced pancreatic cancer: Update.

The phase I study of concurrent chemoradiotherapy using a combination of gemcitabine and nab-paclitaxel for unresectable locally advanced pancreatic cancer: Update.

Abstract Poster

Authors

null

Tatsuya Ioka

Hepatobiliary and Pancreatic Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan

Tatsuya Ioka , Kazuhiro Katayama , Ryoji Takada , Kazuyoshi Ohkawa , Hidenori Takahashi , Teruki Teshima

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

UMIN000012254

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 462)

DOI

10.1200/JCO.2017.35.4_suppl.462

Abstract #

462

Poster Bd #

M2

Abstract Disclosures

Similar Posters

Poster

2018 Gastrointestinal Cancers Symposium

Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.

Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.

First Author: Suguru Yamada

First Author: Lyudmyla Derby Berim

First Author: Angela Tatiana Alistar

First Author: Yusuke Hashimoto